News & Blog

April 19, 2023 | Blog Post
Proteins: Translating Structure into Function
Read More
March 30, 2023 | Press Release
ProJenX Announces Formation of Scientific Advisory Board
Read More
March 28, 2023 | Blog Post In The News
MEC Portfolio Company Aspen Neuroscience Featured in Wall Street Journal for Parkinson’s Disease Research
Read More
March 27, 2023 | In The News
WALL STREET JOURNAL: The Personalized Stem Cells That Could One Day Treat Parkinson’s and Heart Failure
Read More
March 15, 2023 | In The News
ENDPOINT NEWS EXCLUSIVE: Sanofi, Astellas venture arms add cash to Avilar’s ‘ATAC’ mission
Read More
February 28, 2023 | Blog Post
Looking Ahead Series: Insights on Innovation from the MEC Council and the Brightest Minds
Read More
February 16, 2023 | Press Release
AVILAR THERAPEUTICS INCREASES FINANCING TO $75 MILLION TO ADVANCE PIPELINE OF NOVEL EXTRACELLULAR PROTEIN DEGRADERS
Read More
February 15, 2023 | Blog Post
Medical Excellence Foundation Announces First MERIT Grant
Read More
January 25, 2023 | In The News
Endpoints News: A stem cell pioneer sent an experiment into space. Patients are the next frontier
Read More
January 24, 2023 | Blog Post
Our Sophomore Year: A Review of 2022
Read More